Chondroitin Sulfate Sodium

硫酸软骨素钠

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameChondroitin Sulfate Sodium
Drug Alias Name软骨素硫酸钠盐硫酸软骨素钠盐LacryposChonsuridCondrosan +[9] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionLeukocyte elastase inhibitors
TargetsLeukocyte elastase
Therapy Area/IndicationsBack PainHyperlipidemiasCystitis, Interstitial +[15] 
Global Approved IndicationsBack PainHyperlipidemiasNeuralgia +[6] 
Approved Indications in ChinaHyperlipidemias
Original Approved Country/TerritoryJapan
Original Approved Date1963/11/01
Country/TerritoryCzechiaBelgiumCanada +[8] 
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesN/A
China Registration ClassN/A

Develop Information

Active CompaniesTianjin Junan Biopharmaceutical Co LtdJiangsu Zetai Pharmaceutical Co LtdNippon Shinyaku Co Ltd
Inactive CompaniesIbsa Institut Biochimique SaBioiberica SaAmerican Watson Pharmaceutical Co Ltd
Active IndicationsBack PainHyperlipidemiasKeratitis +[9] 
Inactive IndicationsCystitis, InterstitialMusculoskeletal PainSynovitis +[6] 

Other Information

ATC CodeM01AX25
Related LinksWikipediaDrugBankKEGG